🇺🇸 FDA
Patent

US 7511053

Spiroazacyclic compounds as monoamine receptor modulators

granted A61PA61P1/14A61P25/00

Quick answer

US patent 7511053 (Spiroazacyclic compounds as monoamine receptor modulators) held by ACADIA Pharmaceuticals Inc. expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADIA Pharmaceuticals Inc.
Grant date
Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P1/14, A61P25/00, A61P25/06, A61P25/14